SOUTH EASTON, MA / ACCESSWIRE / August 13, 2014 / Pressure BioSciences Inc. (OTCQB: PBIO) will host a conference call and live webcast to discuss the results of the second quarter 2014, to be held Thursday, August 14, 2014 at 4:30 PM Eastern Time.
To participate in this event, dial 877-407-8031 domestically, or 201-689-8031 internationally, approximately 5 to 10 minutes before the beginning of the call.
If you are unable to participate during the live teleconference, you may access the replay by dialing 877-660-6853 domestically or 201-612-7415 internationally, referencing conference ID #13589201. The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on November 14, 2014.
About Pressure BioSciences Inc.
Pressure BioSciences, Inc. ("PBI") (PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary development and sales efforts are in the biomarker discovery, drug discovery and design, and forensics areas. Customers also use our products in other areas, such as bio-therapeutics characterization, soil & plant biology, vaccine development, and counter-bioterror applications.
For more information about PBI and this press release, please click on the following link: www.pressurebiosciences.com
Please visit us on Facebook, LinkedIn, and Twitter.
SOURCE: Pressure BioSciences Inc.
Leave a comment...